Article

FDA NEWS DIGEST -- DECEMBER 31, 2001

Author(s):

BioPharm International Editors

Preapproval inspection of anthrax facility, new defribilator, new FDA group on safety and risk, and noodle recall.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Related Content
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
September 16th 2025

CSL Backs Late-Stage Development of VarmX’s Coagulation Therapy VMX-C001X

Feliza Mirasol
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
September 16th 2025

The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game

G-CON
Creative image of embryonic stem cells, cellular therapy. 3d illustration | Image Credit: © pinkeyes - © pinkeyes - stock.adobe.com
September 16th 2025

Limula’s LimONE System Targets Consistency in Stem Cell Transplants

Feliza Mirasol
Mastering Antibody-Drug Conjugates
September 16th 2025

Mastering Antibody-Drug Conjugates

BIOVECTRA
Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com
September 16th 2025

Monte Rosa and Novartis Partner to Target Undruggable Immunology Pathways with Degraders

Feliza Mirasol
Site Logo
September 16th 2025

Industrialize Autologous Therapies

Catalent
© 2025 MJH Life Sciences

All rights reserved.